Wintergreen Emergency Egress Act
Sponsored By: Representative McGuire
In Committee
Summary
A mandatory right-of-way for an emergency exit across Blue Ridge Parkway land near Wintergreen, Virginia. This bill would require the Secretary of the Interior to issue a right-of-way shown on a specific map once required environmental and planning analyses are finished and reported to designated congressional committees.
Show full summary
- Families and local residents: Would gain a planned emergency egress corridor near milepost 9.6 intended to help evacuations during fire emergencies.
- Emergency responders and planners: Would see a requirement for analyses of alternatives that avoid Federal land when possible and an analysis of expected fire ecology behavior before the right-of-way can be issued. Those reviews must include the National Environmental Policy Act and related federal reviews and be reported to the House Natural Resources Committee and the Senate Energy and Natural Resources Committee.
- Project scope and limits: The authorization is tied to the corridor depicted on the map dated September 2024, creating a narrowly defined alignment for the egress.
Bill Overview
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
Emergency exit road near Wintergreen
This bill would require the Secretary of the Interior to issue a right-of-way for an emergency exit on National Park Service land along the Blue Ridge Parkway near Wintergreen, Virginia. The right-of-way would follow the alignment shown as “Proposed Egress” on the map titled "Blue Ridge Parkway, Proposed Wintergreen Emergency Egress Near Milepost 9.6," map number 601/194,694, dated September 2024. Before issuing the right-of-way, the Secretary would have to report to the House Committee on Natural Resources and the Senate Committee on Energy and Natural Resources that: an evaluation of alternatives avoiding Federal land (including whether existing trails can be converted to roads) is complete; an analysis of expected fire-ecology behavior for the corridor is complete; and required reviews under the National Environmental Policy Act (42 U.S.C. 4321 et seq.) and division A of subtitle III of title 54 are complete. Once those analyses and reviews are reported to the two committees, the Secretary would be required to issue the right-of-way as depicted.
Sponsors & CoSponsors
Sponsor
McGuire
VA • R
Cosponsors
Wittman
VA • R
Sponsored 12/2/2025
McClellan
VA • D
Sponsored 12/2/2025
Griffith
VA • R
Sponsored 12/2/2025
Vindman
VA • D
Sponsored 12/2/2025
Cline
VA • R
Sponsored 12/2/2025
Walkinshaw
VA • D
Sponsored 12/2/2025
Kiggans (VA)
VA • R
Sponsored 12/2/2025
Roll Call Votes
No roll call votes available for this bill.
View on Congress.govRelated Bills
HR3151 — SHIPS for America Act of 2025
Rebuild U.S. commercial shipbuilding and a U.S.-flag strategic fleet by pairing new tax credits, grants, and operating payments with stronger cargo-preference rules and workforce and innovation programs to restore domestic capacity and sealift readiness. It centralizes maritime strategy in a White House advisor and a Maritime Security Board and funds a broad set of industrial, port, and training programs to favor U.S.-built, U.S.-crewed vessels.
HR842 — Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Would expand Medicare to cover multi-cancer early detection screening tests. It defines eligible tests as certain FDA-cleared or approved genomic blood tests or comparable biological-sample tests and directs the Secretary to use the national coverage determinations process to decide when they are covered.
HR2048 — Metastatic Breast Cancer Access to Care Act
Ends Social Security and Medicare waiting periods for people with metastatic breast cancer. This bill would add “metastatic breast cancer” to the Social Security Act provisions that remove the waiting period for disability insurance benefits and would waive the 24-month Medicare waiting period, allowing affected individuals to access disability benefits and Medicare coverage without those delays.
HR5058 — To designate the facility of the United States Postal Service located at 46164 Westlake Drive in Sterling, Virginia, as the "Firefighter Trevor Brown Post Office Building".
Designates the United States Postal Service facility at 46164 Westlake Drive in Sterling, Virginia as the 'Firefighter Trevor Brown Post Office Building.' This bill would also treat any reference in federal laws, maps, regulations, documents, or other records to that facility as a reference to the new name.
HR6317 — To designate the facility of the United States Postal Service located at 12109 New Kent Highway in New Kent, Virginia, as the "Patricia Paige Post Office".
This bill would designate the United States Postal Service facility at 12109 New Kent Highway in New Kent, Virginia, as the Patricia Paige Post Office. That official name would be used in federal laws, maps, regulations, and other government records when referring to this facility.
HR1262 — Mikaela Naylon Give Kids a Chance Act
Speeds and strengthens pediatric cancer drug development. It expands which cancer products companies must study in children, reshapes organ transplant network governance and fees, and adds new FDA international and transparency steps. - Children with cancer and researchers: Requires pediatric studies that produce clinically meaningful data on dosing, safety, and early effectiveness and widens the kinds of drug combinations studied. It also sets aside $25 million for pediatric drug studies in each of fiscal years 2026, 2027, and 2028. - Transplant patients and transplant network members: Changes Organ Procurement and Transplantation Network governance and financing by allowing quarterly registration fees, requiring those fees fund OPTN operations, improving electronic health record integration, and calling for a GAO review within two years. - FDA partners and drug makers: Creates an Abraham Accords Office to boost regulatory coordination and technical assistance abroad, and forces more transparency during generic (ANDA) reviews about whether generics are qualitatively and quantitatively the same as listed drugs. It also raises the Medicare Improvement Fund amount from $1.4 billion to $2.6 billion. Increases federal outlays by roughly $1.3 billion, driven by a $1.2 billion boost to the Medicare Improvement Fund and $75 million for pediatric studies, adding to federal spending.
Take It Personal
Get Your Personalized Policy View
Create a free account to save research, track policy impacts, and unlock your personalized versions of these pages.
Already have an account? Sign in